Vertex Pharmaceuticals (VRTX) Gross Profit (QoQ) (2009 - 2026)

Vertex Pharmaceuticals (VRTX) Gross Profit (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.66%
Mar 31, 2026 -4.77%
Dec 31, 2025 2.34%
Sep 30, 2025 4.08%
Jun 30, 2025 6.23%
Mar 31, 2025 -3.27%
Dec 31, 2024 4.59%
Sep 30, 2024 4.64%
Jun 30, 2024 -3.16%
Mar 31, 2024 9.22%
Dec 31, 2023 -0.70%
Sep 30, 2023 -0.91%
Jun 30, 2023 3.64%
Mar 31, 2023 4.38%
Dec 31, 2022 -1.25%
Sep 30, 2022 5.71%
Jun 30, 2022 4.47%
Mar 31, 2022 1.45%
Dec 31, 2021 4.44%
Sep 30, 2021 11.64%